Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations

Choi, J. P., Wang, R., Yang, X., Wang, X., Wang, L., Ting, K. K., Foley, M., Cogger, V., Yang, Z., Liu, F., Han, Z., Liu, R., Baell, J., Zheng, X.
American Association for the Advancement of Science (AAAS)
Published 2018